Stockreport
3 Things In Biotech, April 1: Fate's Omens, Mallinckrodt's Trial, Insmed's Journey [Seeking Alpha]
Last insmed, inc earnings: 10/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF
3 Things In Biotech, April 1: Fate's Omens, Mallinckrodt's Trial, Insmed's JourneySummaryFate Therapeutics shows early promise in ovarian cancer.Mallinckrodt on deck for its hyperbilirubinemia drug.Insmed demands its day with the FDA.
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INSM | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INSM alerts
INSM alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc news events
Weekly update
A roundup of the hottest topics
INSM
NEWS
NEWS
- Insmed to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Friday, February 22, 2019[PR Newswire]
- Insmed Incorporated (NASDAQ: INSM) was upgraded by analysts at JMP Securities from a "market perform" rating to an "outperform" rating.[MarketBeat]
- Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.[MarketBeat]
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)[PR Newswire]
- Insmed Incorporated (NASDAQ: INSM) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating.[MarketBeat]
- More
INSM
SEC Filings
SEC Filings
- 2/14/19 - Form SC
- 2/14/19 - Form SC
- 2/13/19 - Form SC
- INSM's page on the SEC website
- More